AEW makes first European life sciences acquisition with Copenhagen investment

Sydmarken 5

AEW as made its first acquisition in the emerging European life sciences sector with the purchase of Sydmarken 5, a fully let asset in the Medicon Valley of Copenhagen, Denmark. 

AEW has made the acquisition on behalf of its recently launched pan-European open ended fund EUROCORE which has closed on EUR415 million of equity commitments to date. The fund aims to provide stable, long term income returns by investing in a future-proof diversified portfolio of core assets.
 
The Sydmarken life science campus offers a total of 32,755 sq m of space including specialist laboratories as well as modern offices. All of the buildings are fully let on long leases with an average lease to expiry of c14 years to well known, fast growing businesses in the pharma, medical and food production industries. The main occupiers on the campus include Zealand Pharma and Ferrosan Medical Devices.
 
Copenhagen’s life science industry is a world leader in R&D, clinical trials and drug development, forming a central pillar of the Medicon Valley bi-national life science cluster spanning eastern Denmark to southern Sweden. Sydmarken is located in the Gladsaxe Municipality which is situated 10 km from all three of Denmark’s major universities providing access to a highly talented workforce. The area has also been home to many of the country’s largest companies for decades and has a strong focus on healthcare. Denmark is regarded as one of the strongest economies in Europe, a view underpinned by its low unemployment rates, balanced state budget and GDP per capita which is one of the highest in the world.
 
Christina Ofschonka, Senior Fund Manager for EUROCORE at AEW, says: “We have been seeking opportunities in the emerging life sciences sector given the highly resilient income it offers driven by strong underlying fundamentals. Across Europe the sector is characterised by low supply of good quality and highly specific stock that occupiers require, coupled with increasing demand that was already fuelled by increased government and private investment into healthcare and pharmaceutical research and manufacturing, even before the pandemic brought it into even sharper focus. Copenhagen’s life sciences industry is seen as a world leader and this asset is at the forefront of that reputation.”
 
EUROCORE has a strong current pipeline of assets targeting the changing demand for real estate being brought about by ongoing urbanisation, demographic changes and the rise of new technologies. This pipeline will allow the Fund to both deploy the committed capital quickly and grow its diversified and futureproof portfolio.
 
AEW was advised by Bech-Bruun, KHR and Colliers.